NUZ 5.00% 19.0¢ neurizon therapeutics limited

Ann: PharmAust receives ethics approval for Phase I trial in MND, page-26

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 927 Posts.
    lightbulb Created with Sketch. 596
    In due course PAA expects MPL will receive orphan drug designation by the FDA.
    Really.. expecting that while the first enquiry Phase I Trial is still 2 qtrs away from starting.. a big call from the quiet one
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
-0.010(5.00%)
Mkt cap ! $93.42M
Open High Low Value Volume
20.5¢ 20.5¢ 19.0¢ $61.57K 312.5K

Buyers (Bids)

No. Vol. Price($)
4 108476 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 5598 1
View Market Depth
Last trade - 16.10pm 14/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.